37 Sentences With "loose stools" | Random Sentence Generator

Gastrointestinal symptoms such as loose stools and abdominal discomfort are common.

Symptoms of a food intolerance include abdominal pain, bloating, cramping, diarrhea, and loose stools.

It's why we develop loose stools, stomach pain, nausea, or vomit under crisis, she tells me.

Again, Ahuja says that short-term loose stools are probably not dangerous, but are definitely annoying.

Some feel a little bit of abdominal discomfort, some have nausea or loose stools, and some even lose a little weight.

Fake fish can equal loose stools and lost wages ($25 billion annually as a country in 2015) for something that isn't what you ordered.

Abdominal discomfort, nausea, loose stools, and mild weight loss are the most common signs that your body has this tape worm that can grow up to 30 feet long.

Also, D-mannose can have side effects: it can cause loose stools, and, because it is a sugar, it creates risk for diabetes, noted Dr. Lee Riley, a professor of epidemiology and infectious diseases at the University of California, Berkeley.

The most frequent adverse events with saquinavir in either formulation are mild gastrointestinal symptoms, including diarrhoea, nausea, loose stools and abdominal discomfort. Invirase is better tolerated than Fortovase.

Complications include anaesthetic risks, infection, bleeding and perforation of the bowel. Frequent loose stools may cause nappy rash. Toilet training may also pose problems. Occasionally a temporary stoma is required.

No longer a first-line treatment for rheumatoid arthritis, due to "its adverse effects, most of which are associated with long-term use for chronic disease. The most common adverse effects are gastrointestinal complaints such as loose stools, abdominal cramping and watery diarrhoea, which can develop in the early months of treatment. The development of loose stools occurs in 40 % of patients, while watery diarrhoea is reported in just 2–5 % of patients, and in most cases these symptoms were alleviated by reducing or splitting the dose".

Chilliness, cold limbs, dull-pale face, no thirst, listlessness, sweating, loose stools, clear-abundant urine, a deep slow or weak pulse and a pale tongue with a thin white coating. Empty cold arises from a deficiency of Yang.

The incidence of overdose with ezetimibe is rare; subsequently, few data exist on the effects of overdose. However, an acute overdose of ezetimibe is expected to produce an exaggeration of its usual effects, leading to loose stools, abdominal pain, and fatigue.

Chilliness, cold limbs, no thirst, pale face, abdominal pain., aggravated on pressure, desire to drink warm liquids, loose stools, clear abundant urine, Deep-full-tight pulse and a pale tongue with thick white coating. Full cold is generated by an excess of Yin.

Serum-derived bovine immunoglobulin/protein isolate (SBI) is a medical food product derived from bovine serum obtained from adult cows in the United States. It is sold under the name EnteraGam. EnteraGam (SBI) is intended for the dietary management of chronic diarrhea and loose stools. It must be administered under medical supervision.

The real challenge is to find an enema capable of cleaning the colon completely. Soiling episodes or "accidents" occur when there is an incomplete cleaning of the bowel. Children with loose stools and diarrhea (colonic hypermotility): This group of children has an overactive colon. Rapid transit of stool results in frequent episodes of diarrhea.

The other type is dysenteric gastroenteritis, which causes loose stools filled with blood and mucus. Dysenteric gastroenteritis is the most severe out of the two types, and can last for several weeks. A. hydrophila is also associated with cellulitis. It also causes diseases such as myonecrosis and eczema in people with compromised or suppressed (by medication) immune systems.

Because octreotide inhibits gastrointestinal and pancreatic function, long-term use causes digestive problems such as loose stools, nausea, and gas in one third of people. In addition, approximately 25 percent of people with acromegaly develop gallstones, which are usually asymptomatic. In some cases, octreotide treatment can cause diabetes due to the fact that somatostatin and its analogues can inhibit the release of insulin.

Cyst and imago of Giardia lamblia, the protozoan parasite that causes giardiasis. The species was first observed by Antonie van Leeuwenhoek in 1681. Antonie van Leeuwenhoek observed and illustrated Giardia lamblia in 1681, and linked it to "his own loose stools". This was the first protozoan parasite of humans that he recorded, and the first to be seen under a microscope.

The only side effect observed was mild loose stools (12% in treatment group vs. 3% in the placebo group). Further studies have shown that most active estrogenic compound in Menerba is liquiritigenin, derived from the root of Glycyrrhizae uralensis Fisch, one of the 22 botanically derived ingredients found in Menerba. In a mouse xenograft model, liquiritigenin activated multiple ER regulatory elements and native target genes with ERβ but not ERα.

Even though a biliblanket may cause loose stools and skin rashes, it is considered safe for the most part. This device is mostly used for 2 to 3 days only. In severe situations, intravenous fluids may be needed to be given to the patient. Phototherapy uses photons of energy that are infused and absorbed by bilirubin located in superficial capillaries and subcutaneous tissues and interstitial spaces of the skin.

One common side effect that is experienced by babies who are receiving phototherapy treatment is more frequent and loose stools. The color of these stools are usually a greenish color; however, this is normal because that is the way bilirubin is removed from the body. As bilirubin levels return to normal and phototherapy is no longer needed, the frequency of bowel movements and the color of the stools will return back to normal.

The fat substitute Olestra, used to reduce digestible fat in some foods, was reported to cause leakage in some consumers during the test- marketing phase. As a result, the product was reformulated before general release to a hydrogenated form that is not liquid at physiologic temperature. The U.S. Food and Drug Administration warning indicated excessive consumption of Olestra could result in "loose stools"; however, this warning has not been required since 2003.

WAD is typically self-limited, generally resolving without specific treatment. Oral rehydration therapy with rehydration salts is often beneficial to replace lost fluids and electrolytes. Clear, disinfected water or other liquids are routinely recommended. Hikers who develop three or more loose stools in a 24-hour period – especially if associated with nausea, vomiting, abdominal cramps, fever, or blood in stools – should be treated by a doctor and may benefit from antibiotics, usually given for 3–5 days.

If diarrhea becomes severe (typically defined as three or more loose stools in an eight-hour period), especially if associated with nausea, vomiting, abdominal cramps, fever, or blood in stools, medical treatment should be sought. Such patients may benefit from antimicrobial therapy. A 2000 literature review found that antibiotic treatment shortens the duration and severity of TD; most reported side effects were minor, or resolved on stopping the antibiotic. The antibiotic recommended varies based upon the destination of travel.

Starting in 1996, an FDA-mandated health warning label read "This Product Contains Olestra. Olestra may cause abdominal cramping and loose stools. Olestra inhibits the absorption of some vitamins and other nutrients. Vitamins A, D, E, and K have been added"."FDA approves fat substitute, Olestra", retrieved December 6, 2006 These symptoms, normally occurring only by excessive consumption in a short period of time, are known as steatorrhea, and caused by an excess of fat in stool.

The large intestine meridian communicates with the lung (), with which it is externally-internally related. The two paired organs are associated with the metal element () and the emotion of grief. The main function of the large intestine is to receive the waste material sent down from the small intestine, absorb its fluid content, and form the remainder into faeces to be excreted. Pathological changes of the large intestine will lead to dysfunction in this transportation function, resulting in loose stools and constipation.

The patient described in Aretaeus' work had stomach pain and was atrophied, pale, feeble and incapable of work. The diarrhoea manifested as loose stools that were white, malodorous and flatulent, and the disease was intractable and liable to periodic return. The problem, Aretaeus believed, was a lack of heat in the stomach necessary to digest the food and a reduced ability to distribute the digestive products throughout the body, this incomplete digestion resulting in the diarrhoea. He regarded this as an affliction of the old and more commonly affecting women, explicitly excluding children.

In 1681, Antonie van Leeuwenhoek observed and illustrated the protozoan parasite Giardia lamblia, and linked it to "his own loose stools". This was the first protozoan parasite of humans to be seen under a microscope. A few years later, in 1687, the Italian biologists Giovanni Cosimo Bonomo and Diacinto Cestoni described scabies as caused by the parasitic mite Sarcoptes scabiei, marking it as the first disease of humans with a known microscopic causative agent. Ronald Ross won the 1902 Nobel Prize for showing that the malaria parasite is transmitted by mosquitoes.

Only a few human studies have been done to determine the adverse effects of resveratrol, all of them preliminary with small participant numbers. Adverse effects resulted mainly from long-term use (weeks or longer) and daily doses of 1000 mg or higher, causing nausea, stomach pain, flatulence, and diarrhea. In a year-long preliminary clinical trial in people with Alzheimer's disease, the most frequent adverse effects were nausea and weight loss. A 2018 review of resveratrol effects on blood pressure found that some people had increased frequency of bowel movements and loose stools.

Side effects when used as drugs may include loss of appetite, nausea, vomiting, loose stools, vivid dreams at night, dehydration, rash, bradycardia, peptic ulcer disease, seizures, weight loss, rhinorrhea, salivation, muscle cramps, and fasciculations. ChEIs are indirect-acting parasympathomimetic drugs. It came to light during the Berlin Charité hospital treatment for poisoning of Russian dissident Alexei Navalny that a nerve agent known as belonging to the Novichok agents is a ChEI. On October 6, 2020, OPCW published an official statement stating than substance found in the body of Navalny is not in the list of prohibit substances.

Additionally, some varieties of fat-free chips have been made using artificial, and indigestible, fat substitutes. These became well known in the media when an ingredient many contained, Olestra, was linked in some individuals to abdominal discomfort and loose stools. Many other products might be called "crisps" in Britain, but would not be classed as "potato chips" because they are not made with potato or are not chipped (for example, Wotsits, Quavers, Skips, Hula Hoops, and Monster Munch). Sweet potato chips are eaten in Korea, New Zealand, and Japan; parsnip, beetroot, and carrot crisps are available in the United Kingdom.

The first host to be noticed in ancient times was human: human parasites such as hookworm are recorded from ancient Egypt from 3000 BC onwards, while in ancient Greece, the Hippocratic Corpus describes human bladder worm. The medieval Persian physician Avicenna recorded human and animal parasites including roundworms, threadworms, the Guinea worm and tapeworms. In Early Modern times, Francesco Redi recorded animal parasites, while the microscopist Antonie van Leeuwenhoek observed and illustrated the protozoan Giardia lamblia from "his own loose stools". Hosts to mutualistic symbionts were recognised more recently, when in 1877 Albert Bernhard Frank described the mutualistic relationship between a fungus and an alga in lichens.

Pooled data from clinical trials suggest that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about more than those not taking the drug over the course of a year. Orlistat also modestly reduces blood pressure and appears to prevent the onset of type 2 diabetes, whether from the weight loss itself or other effects. It reduces the incidence of diabetes type II in people who are obese around the same amount that lifestyle changes do. Benefits aside, however, orlistat is noted for its gastrointestinal side effects (sometimes referred to as treatment effects), which can include steatorrhea (oily, loose stools).

The primary side effects of the drug are gastrointestinal-related, and include steatorrhea (oily, loose stools with excessive flatus due to unabsorbed fats reaching the large intestine), fecal incontinence and frequent or urgent bowel movements. To minimize these effects, foods with high fat content should be avoided; the manufacturer advises consumers to follow a low-fat, reduced-calorie diet. Oily stools and flatulence can be controlled by reducing the dietary fat content to somewhere in the region of 15 grams per meal. The manual for Alli makes it clear that orlistat treatment involves aversion therapy, encouraging the user to associate eating fat with unpleasant treatment effects.

Retrieved October 12, 2007 The FDA also agreed with P&G; that the "label statement could be misleading and cause consumers of olestra to attribute serious problems to olestra when this [was] unlikely to be the case". When removing the olestra warning label, the FDA cited a six-week P&G; study of more than 3000 people showing the olestra-eating group experienced only a small increase in bowel movement frequency compared to the control group. The FDA concluded that "subjects eating olestra-containing chips were no more likely to report having had loose stools, abdominal cramps, or any other GI symptom compared to subjects eating an equivalent amount of [potato] chips".FDA Docket; p 46372.